Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 161 participants.

Also called NCT01817699

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 161 participants (enrolled count) (from the registry)
Sponsor
CANDLE-KIT Trial Study Group (from the registry)
Registry
  • NCT NCT01817699
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01817699. Randomized; no masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2018-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
Acronym
CANDLE-KIT
Condition
Kidney Transplantation
Condition
Anemia
Condition
Vitamin D Deficiency
Condition
Renal Insufficiency, Chronic
Intervention (Other)
High Hb target
Intervention (Dietary supplement)
cholecalciferol
Lead sponsor
CANDLE-KIT Trial Study Group (class: other)
Collaborator
Chugai Pharmaceutical (class: industry)
Collaborator
Japanese Society for the Promotion of Science (class: other)
Collaborator
The Japan Kidney Foundation (class: other)
Collaborator
Roche Diagnostics GmbH (class: industry)

Record details

Record id
cardio:ct-nct01817699
Content hash
71fb232e4f62981e74259548c39cd57a78053246ba2b572936f197649e66044a